Premium Nahrungsergänzungsmittel | artgerecht

Urea Infusion – Effects, Uses and Risks

A urea infusion is a medical treatment in which urea is administered intravenously. It is used to regulate blood urea levels or to achieve specific therapeutic effects such as reducing brain pressure.

Regular tips about health Regular tips about health

Things worth knowing about "Urea Infusion"

A urea infusion is a medical treatment in which urea is administered intravenously. It is used to regulate blood urea levels or to achieve specific therapeutic effects such as reducing brain pressure.

What Is a Urea Infusion?

A urea infusion refers to the intravenous administration of urea (chemically: carbamide) as a medical therapy. Urea is a naturally occurring substance in the body, produced as an end product of protein metabolism in the liver and excreted by the kidneys. In clinical medicine, urea can be administered therapeutically to treat specific conditions or support physiological processes.

Indications

Urea infusions are used in several medical contexts:

Treatment of cerebral edema: Urea acts osmotically and helps draw excess fluid out of brain tissue, thereby reducing elevated intracranial pressure.
Management of hyponatremia: In cases of dangerously low blood sodium levels, particularly in the syndrome of inappropriate antidiuretic hormone secretion (SIADH), urea can be used to safely raise sodium levels.
Osmotherapy: Urea is used as an osmotically active agent to control fluid shifts between body compartments.
Support of renal function: In certain clinical settings, controlled urea administration may support kidney function.

Mechanism of Action

Urea is a small, water-soluble molecule with osmotic properties. When administered intravenously, it increases the osmolarity of blood plasma. The resulting osmotic gradient draws water from tissues and cells into the bloodstream. This mechanism is primarily used therapeutically to remove fluid from brain tissue and reduce intracranial pressure. Unlike other osmotic agents such as mannitol, urea can cross the blood-brain barrier to a limited extent, which can be advantageous in certain indications.

Administration and Dosage

Urea infusions are administered exclusively under medical supervision in a clinical setting. The dosage depends on the underlying condition, the patient's body weight, and current laboratory values. Typically, a 30% urea solution is infused intravenously. The infusion rate and total volume are adjusted individually to avoid overdose and side effects. Close monitoring of kidney values, electrolytes, and neurological status is essential throughout therapy.

Side Effects and Risks

As with any intravenous therapy, side effects may occur with urea infusions:

Electrolyte imbalances: Fluid shifts can cause imbalances in sodium, potassium, and other electrolytes.
Renal burden: In patients with pre-existing kidney insufficiency, increased urea administration may place additional stress on the kidneys.
Local irritation: Redness or tissue irritation at the infusion site may occur.
Headache and dizziness: As a result of the osmotic effect on the brain, temporary headaches or dizziness may occur.
Thrombophlebitis: Inflammation of the vein at the infusion site is possible.

Contraindications

A urea infusion is not suitable for all patients. It should not be used in cases of:

Severe renal insufficiency without dialysis support
Severe hepatic insufficiency
Hypernatremia (elevated blood sodium levels)
Active intracranial bleeding
Known hypersensitivity to urea

Comparison with Other Osmotic Agents

Several osmotically active substances are available in clinical practice. Mannitol is a commonly used alternative for reducing intracranial pressure, but it has different pharmacokinetics. Urea offers the advantage of being a naturally occurring substance with good tolerability, and it can simultaneously be used in the treatment of hyponatremia, for which mannitol is not suitable. The choice of the appropriate osmotic agent always depends on the specific clinical situation.

References

Bhardwaj A, Bhagat H, Grover VK. Urea for Treatment of Hyponatremia. Indian Journal of Critical Care Medicine, 2015.
Decaux G, Soupart A. Treatment of symptomatic hyponatremia. The American Journal of the Medical Sciences, 2003;326(1):25-30.
European Association for the Study of the Liver (EASL). Clinical Practice Guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology, 2010.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.